GRSD Grandstand
Grandstand earnings company data as of 4:48 AM ET 10/23
History
2 periods, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 12 Nov | EPS | 0.07 | — | — |
| Rev | — | — | — | ||
| FY2026 Q2 | 13 Aug | EPS | — | -0.13 | — |
| Rev | — | $37.8M | — |
Insider trades
Open-market buys and sales by GRSD's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $31K bought by 3 insiders
- None no sales outside a trading plan
- None no planned (10b5-1) sales
-
Kevin Ross McCrystle CEOBuy$3,365 2,901 shares at $1.16 +0.3% to stakeTraded Oct 15 Filed Oct 19
-
Martin Elias Mark CFOBuy$13K 3,860 shares at $3.24 +0.5% to stakeTraded Apr 15 Filed Apr 22
-
Kevin Ross McCrystle COOBuy$2,391 738 shares at $3.24 +0.1% to stakeTraded Apr 15 Filed Apr 22
Also filed in the last 12 months, not counted as buying or selling: 7 option exercises and 2 stock grants.
SEC filings
Recent issuer filings from EDGAR, 24 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 20-F | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.